Bimodal distribution of genomic MLL breakpoints in infant acute lymphoblastic leukemia treatment.
Jung
R
R
Jacobs
U
U
Krumbholz
M
M
Langer
T
T
Keller
T
T
De Lorenzo
P
P
Valsecchi
M G
MG
van der Velden
V H J
VH
Moericke
A
A
Stanulla
M
M
Teigler-Schlegel
A
A
Panzer-Gruemayer
E R
ER
van Dongen
J J M
JJ
Schrappe
M
M
den Boer
M L
ML
Pieters
R
R
Rascher
W
W
Metzler
M
M
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D056905:Chromosome Breakpoints; D015331:Cohort Studies; D004268:DNA-Binding Proteins / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D011495:Histone-Lysine N-Methyltransferase; D006801:Humans; D007223:Infant; D008297:Male; D051788:Myeloid-Lymphoid Leukemia Protein / Q000235:genetics*; D009687:Nuclear Proteins / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D011995:Recombination, Genetic; D015996:Survival Rate; D059005:Topoisomerase II Inhibitors; D035602:Transcriptional Elongation Factors
D004268:DNA-Binding Proteins; D004791:Enzyme Inhibitors; C497422:KMT2A protein, human; D009687:Nuclear Proteins; D015514:Oncogene Proteins, Fusion; D059005:Topoisomerase II Inhibitors; D035602:Transcriptional Elongation Factors; D051788:Myeloid-Lymphoid Leukemia Protein; C081449:AFF1 protein, human; D011495:Histone-Lysine N-Methyltransferase